Governance Classic Home
Fermenta Biotech LtdPharmaceuticalsINE225B01021Consolidated₹475.75+10.40 (+2.23%)Jun-26
Valuation
Market Cap₹1.40K Cr
TTM PE21.89x
Forward PE25.06x
PEG-0.79
Book Value₹121.81
P/B3.91x
TTM EPS₹21.73
Fwd EPS₹18.99
TTM Revenue₹525.66 Cr
TTM PAT₹61.18 Cr
TTM EBITDA₹97.95 Cr
TTM EBIT₹76.16 Cr
Last Qtr PAT₹9.53 Cr
Last Qtr EBITDA₹18.06 Cr
Last Qtr EBIT₹12.86 Cr
Profitability
ROE17.07%
ROCE20.43%
TTM NPM11.64%
TTM EBITDA %18.63%
Curr OPM7.55%
Last OPM8.56%
Curr NPM—
Last NPM—
Curr EPS₹3.40
Last EPS₹4.36
Balance sheet
Equity₹14.58 Cr
Reserve₹343.93 Cr
Total Debt₹109.40 Cr
D/E0.31x
Interest %26.65%
Curr Interest₹2.54 Cr
Price / range
Close₹475.75
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+2.23%
1W+0.15%
1M+4.68%
3M+49.40%
6M+37.48%
1Y+38.91%
2Y+60.10%
3Y+177.24%
5Y+68.17%
Diwali+36.03%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue111.84-6.0%109.88114.24107.12119.02450.25
Other Income4.906.103.435.538.8423.90
Total Income116.74-8.7%115.98117.67112.64127.86474.15
Interest2.542.773.032.593.1111.48
Expenditure-96.59+8.1%-95.89-98.98-91.87-105.10-391.88
PBDT000000
EBITDA22.98+1.8%21.8423.4622.9722.5890.79
Depreciation-5.19-5.08-5.17-5.13-5.55-20.94
EBIT17.79+4.5%16.7618.2917.8417.0369.85
PBT20.15-11.3%29.1616.5920.7722.7289.24
Tax-5.16-7.59-4.83-6.05-6.40-24.96
Equity14.3400000
OPM17.2626.5414.5219.3919.0919.00
Net Profit14.99-7.6%21.5711.7614.7216.2364.28
NPM12.8419.6310.2913.7413.6414.00
EPS5.237.494.045.05022.13

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue450.25+4.6%430.53+40.2%307.09-6.6%328.92-15.2%387.96+4.1%372.82
Other Income23.9011.688.157.567.536.62
Total Income474.15+7.2%442.21+40.3%315.25-6.3%336.48-14.9%395.49+4.2%379.44
Expenditure-391.88-6.5%-367.79-18.3%-310.85+7.4%-335.58+4.9%-352.92-11.6%-316.21
Interest-11.48-14.20-17.05-20.94-17.23-18.08
PBDT000000
EBITDA90.79-9.3%100.11+170.6%36.99-4.6%38.79-48.9%75.94-19.0%93.72
Depreciation-20.94-23.17-23.70-24.51-23.67-19.03
EBIT69.85-9.2%76.94+478.9%13.29-6.9%14.28-72.7%52.27-30.0%74.69
PBT89.24+19.9%74.42+1714.3%-4.61+92.1%-58.69-237.9%42.56-32.7%63.23
Tax-24.96-6.81-14.141.16-12.33-11.26
Equity014.580000
OPM (%)19.0016.83-1.00-17.0011.0017.00
Net Profit64.28-4.9%67.62+460.8%-18.74+67.4%-57.53-290.2%30.24-41.8%51.97
NPM (%)14.0015.29-6.00-17.008.0014.00
EPS (Rs)22.13-4.5%23.18+457.2%-6.49+67.5%-19.94-290.3%10.48-41.8%18.02
CEPS21.9623.18-6.49-19.9410.4317.92

Consolidated

16 lines · 6 periods
MetricJun-26Dec-25Sep-25Jun-25Mar-25FY24-25
Revenue121.82-10.6%137.36130.22136.26139.85469.48
Other Income4.373.125.438.773.8911.82
Total Income126.20-13.0%140.48135.66145.03143.74481.30
Interest2.543.042.583.112.9914.19
Expenditure-111.50+4.6%-120.80-111.57-116.90-111.70-398.09
PBDT000000
EBITDA18.06-36.1%24.9726.6428.2837.01109.80
Depreciation-5.20-5.37-5.41-5.81-5.87-24.22
EBIT12.86-42.8%19.6021.2322.4731.1485.58
PBT14.69-47.7%17.4824.0828.0931.9883.21
Tax-5.16-5.46-6.05-6.401.30-6.81
Equity14.34000014.58
OPM11.6412.4417.7519.3722.2517.29
Net Profit9.53-55.9%12.0218.0321.6033.3276.40
NPM7.558.5613.2914.8923.1815.87
EPS3.40-54.6%4.366.487.4911.7926.35

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 24-25FY 23-24FY 22-23FY 21-22FY 20-21FY 19-20
Revenue469.48+39.9%335.66-4.1%349.94-12.2%398.52+5.6%377.29+28.8%292.95
Other Income11.8211.207.698.148.2512.32
Total Income481.30+38.8%346.86-3.0%357.64-12.1%406.65+5.5%385.54+26.3%305.27
Expenditure-398.09-14.0%-349.31+8.3%-381.04-0.4%-379.71-13.7%-333.91-27.5%-261.85
Interest-14.19-17.05-20.78-17.08-17.98-19.14
PBDT000000
EBITDA109.80+290.5%28.12+56.8%17.93-70.8%61.45-24.8%81.67+25.2%65.24
Depreciation-24.22-24.72-28.25-25.56-20.31-15
EBIT85.58+2417.1%3.40+132.9%-10.32-128.8%35.89-41.5%61.36+22.1%50.24
PBT83.21+943.1%-9.87+81.0%-51.87-292.5%26.94-47.8%51.63+18.9%43.42
Tax-6.81-14.14-1.68-11.88-9.1016.10
Equity14.5800000
OPM (%)17.29-2.85-14.506.6313.3914.22
Net Profit76.40+418.2%-24.01+55.2%-53.55-455.6%15.06-64.6%42.53-28.5%59.52
NPM (%)15.87-6.92-14.973.7011.0319.50
EPS (Rs)26.35+429.8%-7.99+55.2%-17.85-433.6%5.35-66.1%15.77-23.6%20.63
CEPS26.35-7.99-17.855.3315.6920.53

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

24
YearTypeAmountEx-Date
2026Final Dividend3.7505 Aug 2026
2025Final Dividend2.506 Aug 2025
2024Final Dividend1.2506 Aug 2024
2023Final Dividend1.2522 Sep 2023
2022Final Dividend1.2504 Aug 2022
2021Final Dividend2.525 Aug 2021
2020Interim Dividend522 Nov 2019
2019Final Dividend1.2528 Jun 2019
2018Final Dividend1.2519 Sep 2018
2017Final Dividend2.521 Sep 2017
2016Final Dividend2.519 Sep 2016
2015Final Dividend522 Sep 2015
2014Final Dividend2.510 Sep 2014
2014Interim Dividend7.524 Feb 2014
2012Final Dividend1513 Sep 2012
2013Interim Dividend1505 Jul 2012
2012Interim Dividend1523 Feb 2012
2011Final Dividend1015 Sep 2011
2011Interim Dividend1522 Feb 2011
2010Final Dividend7.515 Sep 2010
2011Interim Dividend7.503 Jun 2010
2009Final Dividend7.517 Sep 2009
2010Interim Dividend7.529 Jun 2009
2008Final Dividend1018 Sep 2008

Bonus

2
YearRatioEx-Date
20202:113 Feb 2020
20202:106 Feb 2020

Split

1
YearRatioEx-Date
2018Rs.10/- to Rs.5/-08 Aug 2018
Loading company dashboard...
Fetching ratios, charts, and peers